Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

Name: AnaptysBio, Inc. Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

AnaptysBio, Inc.·Business Segments·2 segments·Rolls up to Pre-Tax Income

Breakdown

Segment	Q1 '26
Biopharma Company	-$50.48M
Royalty Management Company	-$2.36M
Total	-$52.84M

Segments

Biopharma CompanyView metric

Royalty Management CompanyView metric